M. O'donnell

发表

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

J. Niland, N. Kapoor, G. M. Schmidt, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Solid cancers after bone marrow transplantation.

A. Nademanee, J. Niland, A. Krishnan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute Myeloid Leukemia

M. Millenson, F. Appelbaum, M. Tallman, 2020, The New England journal of medicine.

Risk stratification and emerging treatment strategies in acute myeloid leukemia.

M. O'donnell, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.

A. Nademanee, A. Krishnan, M. Slovak, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

C. Bloomfield, M. Millenson, H. Deeg, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Acute myeloid leukemia.

R. Stone, M. Sekeres, M. O'donnell, 2012, Hematology. American Society of Hematology. Education Program.

Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines

M. Millenson, F. Appelbaum, K. Gregory, 2013 .

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

A. Nademanee, A. Krishnan, G. Somlo, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.

D. Weisenburger, G. Marcucci, I. Aldoss, 2019, Clinical lymphoma, myeloma & leukemia.

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.

A. Nademanee, J. Niland, A. Krishnan, 2000, Blood.

Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.

David D. Smith, M. Slovak, K. Gaal, 2009, Cancer genetics and cytogenetics.

Signs and Symptoms Effects on Hematopoiesis

M. O'donnell, 2017 .

Strickland, Eunice S. Wang, Kristina M. Gregory and Maoko Naganuma

M. Millenson, F. Appelbaum, D. Arber, 2013 .

Myelodysplastic syndromes, version 2.2015 featured updates to the NCCN guidelines

C. Bloomfield, R. Bejar, P. Greenberg, 2015 .

NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes.

M. Millenson, H. Deeg, Rashmi Kumar, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Myelodysplastic syndromes clinical practice guidelines in oncology.

C. Bloomfield, M. Millenson, H. Deeg, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Fine needle aspiration cytology of pulmonary carcinoid tumors.

M. O'donnell, C. Anderson, M. Ludwig, 1990, Acta cytologica.

Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission.

A. Nademanee, M. Amylon, R. Hoppe, 1991, Blood.

Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment

J. Richman, S. Bhatia, J. Wolfson, 2018, Cancer Epidemiology, Biomarkers & Prevention.

relapsed non-Hodgkin lymphoma by autologous stem cell transplantation in patients with poor-risk or combination with high-dose etoposide and cyclophosphamide followed A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in

David D. Smith, A. Nademanee, A. Krishnan, 2013 .

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.

David D. Smith, A. Nademanee, A. Krishnan, 2005, Blood.

Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.

A. Nademanee, J. Niland, G. Somlo, 1997, Blood.

High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors.

A. Nademanee, G. Somlo, G. M. Schmidt, 1995, Blood.

Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.

Eileen, A. Nademanee, J. Niland, 1993, Blood.

Platelet and fibrinogen kinetics in canine tumors.

R. Storb, S. Slichter, P. Weiden, 1981, Cancer research.

Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.

Y. Yen, L. Leong, P. Frankel, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.

A. Nademanee, J. Niland, G. Somlo, 1995, Blood.

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.

A. Nademanee, J. Niland, M. Amylon, 1993, The New England journal of medicine.

Original ContributionsVisceral Varicella-Zoster after bone marrow transplantation: report of a case series and review of the literature

D. David, I. Paz, M. O'donnell, 1998 .

Visceral Varicella-Zoster after bone marrow transplantation: report of a case series and review of the literature

B. Paz, D. David, I. Paz, 1998, American Journal of Gastroenterology.

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.

J. Niland, J. Ito, G. M. Schmidt, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase 1 Trial Dose Escalation Study of Tipifarnib on a Week-On, Week-Off Schedule in Relapsed, Refractory or High-Risk Myeloid Leukemia

J. Wright, P. Frankel, S. Forman, 2011, Leukemia.

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.

A. Nademanee, J. Niland, A. Krishnan, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.

P. Bierman, A. Nademanee, R. Krance, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen.

Lixin Yang, G. Marcucci, I. Aldoss, 2019, Blood advances.

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.

A. Nademanee, G. M. Schmidt, D. Snyder, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

M. O'donnell, S. Forman, C. Ries, 1991, Blood.

Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

P. Bierman, S. Forman, G. M. Schmidt, 1987, Blood.

Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.

A. Nademanee, A. Krishnan, M. Slovak, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission

J. Niland, D. Arber, G. Somlo, 2000, Leukemia.

Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.

K. Rowland, S. Taylor, R. Deconti, 1986, Cancer treatment reports.

Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients

D. Arber, M. O'donnell, S. Forman, 2002, Leukemia.

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia.

J. Dipersio, G. Schiller, A. Cashen, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN practice guidelines for the myelodysplastic syndromes

E. Estey, P. Greenberg, J. Bennett, 1998 .

Antibacterial prophylaxis in patients with cancer and neutropenia.

J. Ito, M. O'donnell, B. Tegtmeier, 2006, The New England journal of medicine.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

C. Bloomfield, M. Millenson, H. Deeg, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

G. Marcucci, I. Aldoss, S. Forman, 2018, Haematologica.

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.

J. Niland, K. van Besien, G. Somlo, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.

J. Niland, G. Somlo, K. Margolin, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA DURING FIRST COMPLETE REMISSION

L. R. Hill, A. Nademanee, D. Findley, 1987, Transplantation.

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.

A. Nademanee, D. Arber, S. Forman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

F. Appelbaum, K. Gregory, M. Tallman, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

R. Collins, H. Deeg, S. Feig, 2006, Blood.

A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.

L. R. Hill, R. Krance, S. Forman, 1987, Transplantation proceedings.

Philadelphia chromosome‐positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature

M. Slovak, S. Forman, D. Snyder, 2005, American journal of hematology.

Non-Hodgkins Lymphoma (NHL) by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Combination with High-Dose Etoposide and Cyclophosphamide Followed A Phase I/II Trial of High-Dose Yttrium 90 ibritumomab tiuxetan in

David D. Smith, A. Nademanee, A. Krishnan, 2013 .

Acalculous cholecystitis in bone marrow transplant patients

L. Jardines, S. Forman, J. Terz, 1993, Cancer.

Polymyositis as a Manifestation of Chronic Graft‐Versus‐Host Disease

A. Nademanee, J. Niland, J. Ben-Ezra, 1996, Medicine.

Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

G. Marcucci, I. Aldoss, S. Forman, 2019, American journal of hematology.

T. Slavin, G. Marcucci, I. Aldoss, 2018, Haematologica.

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.

J. Niland, M. Amylon, N. Chao, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

369: Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemia

S. Forman, D. Snyder, P. Parker, 2007 .

Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

J. Dipersio, G. Schiller, A. Cashen, 2008 .

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

J. Niland, A. Krishnan, R. Bhatia, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood Group Incompatibilities and Hemolytic Complications of Hematopoietic Cell Transplantation

M. O'donnell, 2016 .

Peribiliary chloroma: a rare cause of jaundice after bone marrow transplantation.

A. Rotter, D. Radin, M. O'donnell, 1992, AJR. American journal of roentgenology.

Biliary obstruction in hematopoietic cell transplant recipients: an uncommon diagnosis with specific causes

D. David, M. O'donnell, S. Forman, 1999, Bone Marrow Transplantation.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

H. Deeg, R. Bejar, P. Greenberg, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Coccidioidomycosis in bone marrow transplant recipients.

J. Galgiani, J. Ito, T. Evans, 1993, Transplantation.

Equivalence of 2 Effective Graft-Versus-Host Disease Prophylaxis Regimens : Results of a Pro s p e c t i ve

M. Amylon, R. Negrin, G. Long, 2000 .

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.

A. Nademanee, J. Niland, M. Amylon, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma.

M. Territo, S. Forman, A. Levine, 1987, Cancer treatment reports.

Prevention of refractoriness and HLA-alloimmunization using filtered blood products.

L. Hill, I. Sniecinski, M. O'donnell, 1988, Blood.

Acute myeloid leukemia.

M. Millenson, F. Appelbaum, M. Tallman, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

F. Appelbaum, K. Gregory, D. Arber, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection.

F. Grannis, D. Raz, M. O'donnell, 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.

A. Nademanee, J. Zaia, S. Forman, 1988, Transplantation.

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.

H. Deeg, R. Storb, W. Leisenring, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

A. Nademanee, L. Robison, S. Bhatia, 2007, Blood.

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.

A. Nademanee, J. Niland, M. Amylon, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thalidomide as salvage therapy for chronic graft-versus-host disease.

J. Niland, R. Negrin, G. Somlo, 1995, Blood.

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

A. Nademanee, S. Forman, D. Senitzer, 2011, Leukemia & lymphoma.

Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.

R. Storb, S. Slichter, P. Weiden, 1982, Blood.

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

F. Appelbaum, C. Willman, S. Balcerzak, 2002, Blood.

NCCN Acute Myeloid Leukemia , Version 3 . 2017 Clinical Practice Guidelines in Oncology

F. Appelbaum, K. Gregory, D. Arber, 2017 .

Myelodysplastic syndromes.

C. Bloomfield, M. Millenson, H. Deeg, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Acute myeloid leukemia, version 2.2013.

M. Millenson, F. Appelbaum, K. Gregory, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.

A. Nademanee, J. Niland, A. Krishnan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of refractoriness and HLA-alloimmunization using filtered blood products.

L. R. Hill, L. Hill, I. Sniecinski, 1988, Blood.

Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia

G. Marcucci, I. Aldoss, S. Forman, 2017, American journal of hematology.

Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial

T. Zimmerman, Helen X. Chen, J. Doroshow, 2011, British journal of haematology.

Improved results of treatment of adult acute lymphoblastic leukemia.

M. Link, M. O'donnell, S. Forman, 1987, Blood.

Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis.

M. Slovak, D. Arber, M. O'donnell, 1999, Cancer genetics and cytogenetics.

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

An Liu, T. Schultheiss, J. Wong, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute myeloid leukemia clinical practice guidelines in oncology.

J. Byrd, E. Estey, M. Millenson, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.

H. Deeg, J. Anderson, A. Bacigalupo, 1999, Blood.

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

J. Radich, B. Wood, F. Appelbaum, 2014, British journal of haematology.

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.

A. Nademanee, J. Niland, M. Amylon, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older.

D. Findley, J. Zaia, S. Forman, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

M. Amylon, M. Slovak, R. Negrin, 1999, Leukemia.

NCCN Clinical Practice Guidelines Acute myeloid leukemia.

M. Millenson, F. Appelbaum, K. Gregory, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

A. Nademanee, J. Niland, A. Krishnan, 2000, Clinical lymphoma.

Allogeneic bone marrow transplantation as primary therapy for chronic myelomonocytic leukemia

S. Forman, M. O'donnell, K. Blume, 1987, Blut.

Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.

D. Findley, J. Doroshow, R. Krance, 1987, Blood.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.

A. Nademanee, A. Krishnan, G. Somlo, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant Survivor Study functional status of long-term survivors: report from the Bone Marrow Late mortality after allogeneic hematopoietic cell transplantation and

A. Nademanee, L. Robison, S. Bhatia, 2011 .

Phase-2 Trial of an Intensified Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Poor-Risk Leukemia

A. Nademanee, J. Wong, S. Forman, 2010, Bone Marrow Transplantation.

Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.

I. Aldoss, S. Forman, D. Snyder, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelodysplastic syndromes, version 2.2015.

C. Bloomfield, H. Deeg, R. Bejar, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors.

A. Nademanee, D. Findley, R. Krance, 1987, Transplantation.

Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission

L. R. Hill, P. Bierman, A. Nademanee, 1988, Blut: Zeitschrift für die Gesamte Blutforschung.

Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes

David D. Smith, L. Shaffer, B. Ballif, 2010, Molecular Cytogenetics.

Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia

Xiwei Wu, G. Marcucci, Wei Chen, 2021, European journal of haematology.

High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study.

A. Nademanee, K. Margolin, G. M. Schmidt, 1992, Blood.

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

J. Bennett, R. Stone, A. Lundberg, 2009 .

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.

A. Krishnan, S. Forman, D. Senitzer, 2010, Blood.

Early recurrence following induction chemotherapy for stage IV head and neck cancers: Rationale for additional therapy

M. O'donnell, D. Baxter, R. Mohr, 1985, Journal of Surgical Oncology.

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies

M. Angelopoulou, G. Somlo, S. Forman, 2004, Bone Marrow Transplantation.

Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome

M. Slovak, S. Forman, R. Bhatia, 2007, Bone Marrow Transplantation.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2016, The Lancet. Haematology.

Allogeneic bone marrow transplantation for high risk non-hodgkin's lymphoma during first complete remission

P. Bierman, A. Nademanee, S. Forman, 1987, Blut.

Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

J. Radich, B. Wood, F. Appelbaum, 2009 .

Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcomes in a randomised phase 1b trial

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2015, The Lancet. Haematology.

Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.

M. Slovak, S. Forman, D. Senitzer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.

S. Forman, D. Snyder, G. Lazar, 1985, Seminars in oncology.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

D. Weisenburger, G. Marcucci, I. Aldoss, 2017, Haematologica.

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.

K. Chang, S. Forman, J. Alvarnas, 2012, Leukemia research.

Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT)

An Liu, T. Schultheiss, J. Wong, 2014 .

Tacrolimus and Sirolimus as GVHD Prophylaxis for Sibling Donor Hematopoietic Stem Cell Transplant (HCT) Using Three Conditioning Regimens; Fludarabine-Melphalan, FTBI-VP16, and Busulfan-Cyclophosphamide

S. Forman, D. Senitzer, D. Snyder, 2009 .

A Phase I Study of the Farnesyltransferase Inhibitor Tipifarnib in a Week- on Week-Off Dose Schedule in Acute Myelogenous Leukemia.

A. Krishnan, J. Wright, P. Frankel, 2006 .

Clinical Manifestations of Gastrointestinal Granulocytic Sarcoma Requiring Surgical Treatment

B. Paz, Wei Zhou, M. O'donnell, 2001, The American surgeon.

Treatment of perianal infection following bone marrow transplantation

I. Paz, J. Ellenhorn, M. O'donnell, 1996, Diseases of the colon and rectum.

Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.

A. Nademanee, M. Amylon, R. Negrin, 1994, Blood.

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

M. Liedtke, M. Othus, I. Aldoss, 2019, Blood.

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.

L. Beppu, J. Radich, B. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung.

M. Mckneally, J. Horton, J. Ruckdeschel, 1985, Cancer treatment reports.

Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.

S. Bhatia, G. Somlo, V. Bedell, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Group study compared to cytarabine and daunorubicin: a Southwest Oncology myeloid leukemia is not improved with mitoxantrone and etoposide Outcome after induction chemotherapy for older patients with acute

F. Appelbaum, C. Willman, S. Balcerzak, 2013 .

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

M. Slovak, S. Forman, R. Spielberger, 2008 .

Philadelphia chromosome as a recurrent event among therapy‐related acute leukemia

G. Marcucci, I. Aldoss, S. Forman, 2017, American journal of hematology.

Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission

A. Nademanee, M. Amylon, R. Negrin, 1993 .